American Heart Association
American Heart Association
February 07, 2016
3 min watch

VIDEO: ‘Real answers’ on mitral valve repair vs. replacement still unclear

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

ORLANDO, Fla. — Frank Sellke, MD, chief of the division of cardiothoracic surgery at the Warren Alpert Medical School of Brown University and Rhode Island Hospital, discusses results from an NIH-sponsored trial comparing repair vs. replacement for severe ischemic mitral valve regurgitation.

“A lot of surgeons and cardiologists are wondering how to treat these patients,” he said. “The researchers felt that, perhaps with time, repair would be found advantageous over replacement. At 2 years at least, that doesn’t seem to be the case.”

Besides detailing data on the recurrent severe mitral valve regurgitation between the two groups, Selke discusses the rates of readmissions for HF.

“We will have to follow these patients for much longer — hopefully 5 or even 10 years — before we have the real answers.”